Another step toward the cure of metastatic renal cell carcinoma?

Abstract

In the era of an embarrassment of riches for the treatment of metastatic renal cell cancer (mRCC), why do we need an article— much less an accompanying editorial—about the activity of S-1 (Taiho Pharmaceutical, Tokyo, Japan), a fluorinated pyrimidine in mRCC? With the US Food and Drug Administration approval in 2009 of everolimus, pazopanib, and bevacizumab… (More)
DOI: 10.1200/JCO.2010.31.5044

Topics

Cite this paper

@article{Vogelzang2010AnotherST, title={Another step toward the cure of metastatic renal cell carcinoma?}, author={Nicholas J. Vogelzang}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2010}, volume={28 34}, pages={5017-9} }